# Guangxi Yulin Pharmaceutical Group Co. Ltd. – FDA Inspection, Mar 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/guangxi-yulin-pharmaceutical-group-co-ltd/82a89afe-506e-4e84-9dd2-02a225853a04
Source feed: FDA_Inspections

> FDA inspection 1268116 of Guangxi Yulin Pharmaceutical Group Co. Ltd., March 21, 2025. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1268116
- Company Name: Guangxi Yulin Pharmaceutical Group Co. Ltd.
- Inspection Date: 2025-03-21
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 992915 - 2016-09-29](https://www.keypedia.com/records/fda_inspections/guangxi-yulin-pharmaceutical-group-co-ltd/53547aca-4a56-4e32-a161-c8403b574891)
- FDA Inspection 748465 - 2011-09-22

## Related Officers

- [Crystal Monroy](https://www.keypedia.com/people/crystal-monroy/b0414886-fb71-4f35-a453-0ad2baf13bfc)
- [Company Rep](https://www.keypedia.com/people/gavin-t-cua/6f498dd6-2c4b-42e9-8ddc-3c2a7c97afef)

Company: https://www.keypedia.com/companies/guangxi-yulin-pharmaceutical-group-co-ltd/3815cb2a-39f8-4338-9e21-e6dcd7f7a015

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
